儿童急性髓系白血病M2型性染色体缺失的预后意义

贾月萍; 左英熹; 陆爱东; 张乐萍; 刘桂兰

doi:10.7499/j.issn.1008-8830.2015.02.012

PDF(1212 KB)

HTML

中国当代儿科杂志 ›› 2015, Vol. 17 ›› Issue (2) : 168-171. DOI: 10.7499/j.issn.1008-8830.2015.02.012

论著·临床研究

儿童急性髓系白血病M2型性染色体缺失的预后意义

贾月萍, 左英熹, 陆爱东, 张乐萍, 刘桂兰

作者信息 +

Prognostic impact of loss of sex chromosomes in children with acute myeloid leukemia subtype M2

JIA Yue-Ping, ZUO Ying-Xi, LU Ai-Dong, ZHANG Le-Ping, LIU Gui-Lan

Author information +

文章历史 +

摘要

目的探讨儿童急性髓系白血病(AML)M2型性染色体缺失与预后的关系.方法根据细胞遗传学结果将106例AML患儿分为正常核型组(A组,n=26)、不伴性染色体缺失的非正常核型组(B组,n=52)和伴性染色体缺失的非正常核型组(C组,n=28),比较各组患儿预后差异.结果 A、B、C组5年无事件生存率(EFS)分别为38.9%±11.2%、59.3%±7.3%和66.5%±10.5%,其中C组明显高于A组(P=0.035);A、B、C组5年总生存率(OS)分别为54.3%±13.5%、68.1%±7.7%和77.9%±9.8%,三组间比较差异无统计学意义(P>0.05).发生t(8;21)易位的AML患儿58例,5年EFS率为63.3%±7.3%,明显高于正常核型患儿(P=0.015);C组中28例伴性染色体缺失的AML患儿均伴有t(8;21)易位,与不伴性染色体缺失的t(8;21)易位患儿相比,5年EFS率差异无统计学意义(P>0.05).结论儿童AML M2型中性染色体缺失是预后好的染色体核型,该类型大多同时伴有t(8;21)易位;在伴有t(8;21)易位的患儿中,性染色体缺失并没有显示出更好的预后,推测性染色体缺失的非正常核型预后好可能与伴有t(8;21)易位有关.

Abstract

Objective To study the relationship between loss of sex chromosomes and prognosis in children with acute myeloid leukemia (AML) M2 subtype. Methods According to cytogenetic characteristics, 106 children with AML were divided into three groups: patients with normal karyotype (Group A, n=26), patients with abnormal karyotype who had no loss of sex chromosomes (Group B, n=52), and patients with abnormal karyotype who had loss of sex chromosomes (Group C, n=28). Prognosis was compared between the three groups. Results The 5-year event-free survival (EFS) rates of Groups A, B, and C were (38.9±11.2)%, (59.3±7.3)%, and (66.5±10.5)%, respectively; the EFS of Group C was significantly higher than that of Group A (P=0.035). The 5-year overall survival (OS) rates of Groups A, B, and C were (54.3±13.5)%, (68.1±7.7)%, and (77.9±9.8)%, respectively (P>0.05). The 5-year EFS of 58 patients with t(8;21) was (63.3±7.3)%, significantly higher than that of patients with normal karyotype (P=0.015). All the 28 cases in Group C had t(8;21), and their 5-year EFS was not significantly different from that of patients with t(8;21) in Group B (P>0.05). Conclusions Loss of sex chromosomes is a favorable karyotype in children with AML M2 subtype and the patients in this group mostly have t(8;21). Why loss of sex chromosomes indicates a favorable prognosis is probably because it is accompanied by t(8;21) in the patients.

导出引用

贾月萍, 左英熹, 陆爱东, 张乐萍, 刘桂兰. 儿童急性髓系白血病M2型性染色体缺失的预后意义[J]. 中国当代儿科杂志. 2015, 17(2): 168-171 https://doi.org/10.7499/j.issn.1008-8830.2015.02.012

JIA Yue-Ping, ZUO Ying-Xi, LU Ai-Dong, ZHANG Le-Ping, LIU Gui-Lan. Prognostic impact of loss of sex chromosomes in children with acute myeloid leukemia subtype M2[J]. Chinese Journal of Contemporary Pediatrics. 2015, 17(2): 168-171 https://doi.org/10.7499/j.issn.1008-8830.2015.02.012

参考文献

[1] Rubnitz JE, Inaba H. Childhood acute myeloid leukaemia[J]. Br J Haematol, 2012, 159(3): 259-276.
[2] Braoudaki M, Tzortzatou-Stathopoulou F. Clinical cytogenetics in pediatric acute leukemia: an update[J]. Clin Lymphoma Myeloma Leuk, 2012, 12(4): 230-237.
[3] 竺晓凡. 如何提高儿童急性髓系白血病的疗效[J]. 中国当代儿科杂志, 2014, 16(2): 108-110.
[4] 张之南, 沈悌. 血液病诊断及疗效标准[M]. 第2版. 北京: 科学出版社, 1999: 214-218.
[5] Mrozek K, Marcucci G, Nicolet D, et al. Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia[J]. J Clin Oncol, 2012, 30(36): 4515-4523.
[6] Kumari P, LinqappaKacitha B, Obula Reddy C, et al. A rare cytogenetic presentation of acute myeloid leukemia(AML-M2)[J]. Acta Med Iran, 2012, 50(12): 827-830.
[7] 阮敏, 王雅琴, 张梦, 等. 儿童急性髓系白血病细胞遗传学改变与预后分析[J]. 中华血液学杂志, 2012, 33(9): 725-728.
[8] 牧启田, 陈志妹, 楼基余, 等. 154例t(8;21)急性髓系白血病遗传学分析[J]. 浙江大学学报(医学版), 2010, 39(3): 236-240.
[9] Estey EH. Acute myeloid leukemia: 2013 update on risk-stratification and management[J]. Am J Hematol, 2013, 88(4): 318-327.
[10] Appelbaum FR, Kopecky KJ, Tallman MS, et al. The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations[J]. Br J Haematol, 2006, 135(2): 165-173.
[11] Lin P, Chen L, Luthra R, et al. Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrations[J]. Mod Pathol, 2008, 21(8): 1029-1036.
[12] Hann IM, Webb DK, Gibson BE, et al. MRC trials in childhood acute myeloid leukaemia[J]. Ann Hematol, 2004, 83(Suppl 1): S108-S112.
[13] Rege K, Swansbury GJ, Atra AA, et al. Disease features in acute myeloid leukemia with t(8;21)(q22;q22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival[J]. Leuk Lymphoma, 2000, 40(1-2): 67-77.
[14] Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials[J]. Blood, 2010, 116(3): 354-365.
[15] 何亚香, 薛永权, 王红英, 等. 伴有t(8;21)变异易位的急性髓系向血病患儿二例遗传学研究[J]. 白血病·淋巴瘤, 2012, 21(9): 517-519.
[16] 戴海萍, 薛永权, 潘金兰, 等. 一例伴t(1;2l;8)(p36;q22;q22)复杂易位的急性髓系白血病的荧光原位杂交研究[J]. 中华血液学杂志, 2008, 29(8): 557-559.